METABOLISME ET CEC

09/2005

(1) Anderson RE, Brismar K, Barr G, Ivert T. Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery. Eur J Cardiothorac Surg 2005; 28(3):425-430.

(2) Brogan SE, Cahalan MK. Gatifloxacin as a possible cause of serious postoperative hypoglycemia. Anesth Analg 2005; 101(3):635-636.

(3) Carr JM, Sellke FW, Fey M, Doyle MJ, Krempin JA, de la TR et al. Implementing tight glucose control after coronary artery bypass surgery. Ann Thorac Surg 2005; 80(3):902-909.

(4) Casas F, Alam H, Reeves A, Chen Z, Smith WA. A portable cardiopulmonary bypass/extracorporeal membrane oxygenation system for the induction and reversal of profound hypothermia: feasibility study in a Swine model of lethal injuries. Artif Organs 2005; 29(7):557-563.

(5) van Thiel RJ, Koopman SR, Takkenberg JJ, Ten Harkel AD, Bogers AJ. Metabolic alkalosis after pediatric cardiac surgery. Eur J Cardiothorac Surg 2005; 28(2):229-233.

(6) Visser L, Zuurbier CJ, Hoek FJ, Opmeer BC, de Jonge E, de Mol BA et al. Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaesth 2005;